sodium chitosan caprylamide hydroxypropylsulfonate hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

sodium chitosan caprylamide hydroxypropylsulfonate hamilelikte güvenli mi?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment indicating reproductive hazard was found. No peer‑reviewed reproductive or developmental toxicity data were identified for this specific chitosan derivative. As a polymeric chitosan derivative, it is considered to have negligible dermal absorption for adults, supporting a default 'no evidence of reproductive hazard' (CIR/SCCS default). Sources reviewed: ECHA Annex VI, PubChem/CosIng entries where available, PubMed (no reproductive studies), CIR/SCCS absence.

sodium chitosan caprylamide hydroxypropylsulfonate emzirirken güvenli mi?

No evidence of reproductive or lactation toxicity; no data suggesting systemic absorption in adults or transfer into breast milk. No harmonised CLP flags or CIR/SCCS concerns were identified. Therefore default low hazard and negligible exposure for breastfeeding mothers from topical cosmetic use.

sodium chitosan caprylamide hydroxypropylsulfonate bebek cildi için güvenli mi?

No infant‑specific reproductive or systemic toxicity data were identified. The ingredient is a high‑molecular‑weight chitosan derivative and likely shows limited skin penetration, but infant skin barrier immaturity and higher surface‑area‑to‑weight justify an exposure score increased by +1 relative to adults. No evidence was found to increase hazard or mechanism scores for infants.

VeriMom sodium chitosan caprylamide hydroxypropylsulfonate nasıl puanlıyor?

VeriMom sodium chitosan caprylamide hydroxypropylsulfonate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte sodium chitosan caprylamide hydroxypropylsulfonate yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.